Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools.
Sameek SinghSamantha L CooperJacqueline R GlennJessica BeresfordLydia R PercivalJoel D A TyndallStephen J HillLaura E KilpatrickAndrea J VernallPublished in: RSC advances (2018)
G protein-coupled receptors (GPCRs) constitute the largest family of transmembrane receptors in eukaryotes. The adenosine A 1 receptor (A 1 AR) is a class A GPCR that is of interest as a therapeutic target particularly in the treatment of cardiovascular disease and neuropathic pain. Increased knowledge of the role A 1 AR plays in mediating these pathophysiological processes will help realise the therapeutic potential of this receptor. There is a lack of enabling tools such as selective fluorescent probes to study A 1 AR, therefore we designed a series of (benzimidazolyl)isoquinolinols conjugated to a fluorescent dye (31-35, 42-43). An improved procedure for the synthesis of isoquinolinols from tetrahydroisoquinolinols via oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and atmospheric oxygen is reported. This synthetic method offers advantages over previous metal-based methods for the preparation of isoquinolinols and isoquinolines, which are important scaffolds found in many biologically active compounds and natural products. We report the first synthesis of the (benzimidazolyl)isoquinolinol compound class, however the fluorescent conjugates were not successful as A 1 AR fluorescent ligands.
Keyphrases
- living cells
- neuropathic pain
- quantum dots
- cardiovascular disease
- fluorescent probe
- spinal cord
- label free
- spinal cord injury
- healthcare
- type diabetes
- single molecule
- photodynamic therapy
- small molecule
- particulate matter
- protein kinase
- binding protein
- nitric oxide
- metabolic syndrome
- coronary artery disease
- mass spectrometry
- fluorescence imaging
- highly efficient
- molecularly imprinted
- tandem mass spectrometry